95 related articles for article (PubMed ID: 31563836)
1. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.
Pottle A; Thompson G; Barbir M; Bayly G; Cegla J; Cramb R; Dawson T; Eatough R; Kale V; Neuwirth C; Nicholson K; Payne J; Scott J; Soran H; Walji S; Watkins S; Weedon H; Nath Datta DB
Atherosclerosis; 2019 Nov; 290():44-51. PubMed ID: 31563836
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ;
Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658
[TBL] [Abstract][Full Text] [Related]
3. Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.
D'Erasmo L; Bini S; Casula M; Gazzotti M; Bertolini S; Calandra S; Tarugi P; Averna M; Iannuzzo G; Fortunato G; Catapano AL; Arca M;
Eur J Prev Cardiol; 2024 Jun; 31(8):1038-1047. PubMed ID: 38374534
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.
Reijman MD; Kusters DM; Groothoff JW; Arbeiter K; Dann EJ; de Boer LM; de Ferranti SD; Gallo A; Greber-Platzer S; Hartz J; Hudgins LC; Ibarretxe D; Kayikcioglu M; Klingel R; Kolovou GD; Oh J; Planken RN; Stefanutti C; Taylan C; Wiegman A; Schmitt CP
Atherosclerosis; 2024 May; 392():117525. PubMed ID: 38598969
[TBL] [Abstract][Full Text] [Related]
5. Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
Béliard S; Saheb S; Litzler-Renault S; Vimont A; Valero R; Bruckert É; Farnier M; Gallo A
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1447-1454. PubMed ID: 38695169
[TBL] [Abstract][Full Text] [Related]
6. Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.
Stefanutti C
Curr Atheroscler Rep; 2020 Jun; 22(8):38. PubMed ID: 32557261
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand.
Page MM; Hardikar W; Alex G; Bates S; Srinivasan S; Stormon M; Hall K; Evans HM; Johnston P; Chen J; Wigg A; John L; Ekinci EI; O'Brien RC; Jones R; Watts GF
Atherosclerosis; 2023 Dec; 387():117305. PubMed ID: 37863699
[TBL] [Abstract][Full Text] [Related]
8. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR
Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854
[TBL] [Abstract][Full Text] [Related]
9. Hyperlipoproteinaemia(a) - apheresis and emerging therapies.
Vogt A
Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):12-17. PubMed ID: 28185213
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study.
de Boer LM; Reijman MD; Hutten BA; Wiegman A
J Clin Lipidol; 2023; 17(3):415-419. PubMed ID: 37087364
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia.
Wang A; Richhariya A; Gandra SR; Calimlim B; Kim L; Quek RG; Nordyke RJ; Toth PP
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385428
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia.
Al-Baldawi Z; Brown L; Ruel I; Baass A; Bergeron J; Cermakova L; Couture P; Gaudet D; Francis GA; Hegele RA; Iatan I; Mancini GBJ; McCrindle BW; Ransom T; Sherman MH; McPherson R; Genest J; Brunham LR
J Clin Lipidol; 2024; 18(2):e189-e196. PubMed ID: 38281851
[TBL] [Abstract][Full Text] [Related]
13. Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia.
Wen J; Dong Q; Liu G; Gao Y; Li XL; Jin JL; Li JJ; Guo YL
J Clin Lab Anal; 2020 May; 34(5):e23161. PubMed ID: 31859412
[TBL] [Abstract][Full Text] [Related]
14. Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.
Climent E; González-Guerrero A; Marco-Benedí V; García-Andreu MD; Mediavilla-García JD; Suárez-Tembra M; Benaiges D; Pintó X; Pedro-Botet J
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732050
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration
Lancet; 2024 Jan; 403(10421):55-66. PubMed ID: 38101429
[TBL] [Abstract][Full Text] [Related]
16. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
Tromp TR; Hartgers ML; Hovingh GK; Vallejo-Vaz AJ; Ray KK; Soran H; Freiberger T; Bertolini S; Harada-Shiba M; Blom DJ; Raal FJ; Cuchel M;
Lancet; 2022 Feb; 399(10326):719-728. PubMed ID: 35101175
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid analysis in serum of patients with elevated lipoprotein(a) and cardiovascular disease undergoing lipoprotein apheresis.
Mickiewicz A; Marlęga-Linert J; Czapiewska M; Marcinkowska M; Krzesińska A; Kuchta A; Fijałkowski M; Gruchała M; Mika A
J Clin Lipidol; 2024; 18(2):e197-e206. PubMed ID: 38092592
[TBL] [Abstract][Full Text] [Related]
18. Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation.
Schumann F; Kassner U; Spira D; Zimmermann FF; Bobbert T; Steinhagen-Thiessen E; Hollstein T
J Clin Lipidol; 2024 Apr; ():. PubMed ID: 38908966
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity in lipoprotein apheresis: Their role in the era of new lipid-lowering therapies.
Sbrana F; Pianelli M; Luciani R; Bigazzi F; Corciulo C; Ripoli A; Sampietro T; Dal Pino B
J Clin Apher; 2024 Feb; 39(1):e22094. PubMed ID: 37855194
[TBL] [Abstract][Full Text] [Related]
20. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry.
Berman AN; Biery DW; Ginder C; Hulme OL; Marcusa D; Leiva O; Wu WY; Singh A; Divakaran S; Hainer J; Turchin A; Januzzi JL; Natarajan P; Cannon CP; Di Carli MF; Bhatt DL; Blankstein R
Clin Cardiol; 2020 Nov; 43(11):1209-1215. PubMed ID: 32893370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
